BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38812785)

  • 1. 4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment.
    Sellæg K; Schwienbacher R; Kranz M; Aamodt AE; Wirsing AM; Berge G; Hadler-Olsen E; Magnussen SN
    Front Oncol; 2024; 14():1343839. PubMed ID: 38812785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
    Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
    Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8
    Luo J; Shi X; Liu Y; Wang J; Wang H; Yang X; Sun Q; Hui Z; Wei F; Ren X; Zhao H
    Front Immunol; 2024; 15():1302761. PubMed ID: 38390332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.
    Martinet L; Le Guellec S; Filleron T; Lamant L; Meyer N; Rochaix P; Garrido I; Girard JP
    Oncoimmunology; 2012 Sep; 1(6):829-839. PubMed ID: 23162750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High endothelial venules (HEVs) in immunity, inflammation and cancer.
    Blanchard L; Girard JP
    Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High endothelial venules associated with better prognosis in esophageal squamous cell carcinoma.
    Li H; Tang L; Han X; Zhong L; Gao W; Chen Y; Huang J; Wen Z
    Ann Diagn Pathol; 2022 Dec; 61():152051. PubMed ID: 36272333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
    Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
    Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining High Endothelial Venules and Tertiary Lymphoid Structures in Cancer.
    Jones E; Gallimore A; Ager A
    Methods Mol Biol; 2018; 1845():99-118. PubMed ID: 30141010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
    Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
    J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer.
    Hong SA; Hwang HW; Kim MK; Lee TJ; Yim K; Won HS; Sun S; Kim EY; Ko YH
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32823631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression.
    Bento DC; Jones E; Junaid S; Tull J; Williams GT; Godkin A; Ager A; Gallimore A
    Oncoimmunology; 2015 Mar; 4(3):e974374. PubMed ID: 25949892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell Histiocytosis.
    Quispel WT; Steenwijk EC; van Unen V; Santos SJ; Koens L; Mebius R; Egeler RM; van Halteren AG
    Oncoimmunology; 2016 Aug; 5(8):e1164364. PubMed ID: 27622056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.
    Tan MT; Wu JG; Callejas-Valera JL; Schwarz RA; Gillenwater AM; Richards-Kortum RR; Vigneswaran N
    Int J Exp Pathol; 2020 Feb; 101(1-2):45-54. PubMed ID: 32436348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
    Vella G; Guelfi S; Bergers G
    Front Immunol; 2021; 12():736670. PubMed ID: 34484246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
    Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of the tertiary lymphoid structures with the tumor-infiltrating lymphocytes and its prognostic value in gastric cancer.
    Zhang N; Zhang G; Wang D; Liu H; Zhang Y; Ayarick VA; Han X; Lv Y; Wang Y
    Arch Med Sci; 2024; 20(1):255-266. PubMed ID: 38414448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Expression of Th1- and Treg-Associated Chemokine Genes and CD4
    Yamaguchi H; Hiroi M; Mori K; Ushio R; Matsumoto A; Yamamoto N; Shimada J; Ohmori Y
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Tumor-Associated Tertiary Lymphoid Structures in Murine Lung Adenocarcinoma.
    Connolly KA; Nader M; Joshi N
    Methods Mol Biol; 2018; 1845():259-273. PubMed ID: 30141018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.
    Wakasu S; Tagawa T; Haratake N; Kinoshita F; Oku Y; Ono Y; Takenaka T; Oda Y; Shimokawa M; Mori M
    Cancer Immunol Immunother; 2023 Jun; 72(6):1823-1834. PubMed ID: 36688996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.